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Background
The broadly neutralizing monoclonal antibody 4E10
binds a linear, alpha-helical epitope in the membrane-
proximal external region (MPER) of HIV-1 gp41. The
epitope, which lies immediately N-terminal of the single
transmembrane segment of gp41, is partially inserted into
the lipid bilayer. Efforts to design peptide immunogens
containing the 4E10 epitope have been hampered by the
hydrophobic nature of the sequence, and so far no neu-
tralizing immune response could be elicited either with
attached solubility tags, or with the peptide embedded in
a lipophilic environment.
Methods
In an attempt to eliminate the requirement for lipids, we
replaced the amino acids flanking the 4E10 core epitope
by residues that 1) increase the overall hydrophilicity of
the peptide, and 2) maintain the alpha-helical conforma-
tion. Using an in silico approach, we generated a series of
19-mer peptides, in which four variable positions were
occupied by all permutations of six amino acids that ful-
filled the two criteria mentioned above. These 1296 pep-
tides were ranked according to their predicted
hydrophilicity and alpha-helicity. A small set of ''best bet''
peptides was synthesized and analyzed for alpha-helicity
by circular dichroism, and for binding to the 4E10 mono-
clonal antibody by surface plasmon resonance.
Results
One candidate peptide, P2.2, showed improved solubility
in aqueous solution compared to a peptide corresponding
to the parental 4E10 epitope, yet it maintained alpha-heli-
city. Moreover, the binding kinetics of P2.2 to the 4E10
monoclonal antibody were similar to the parental pep-
tide. We are currently testing the immunogenicity of P2.2
conjugated to a carrier protein in a small animal model.
Conclusion
Our results demonstrate that variants of the 4E10 epitope
with improved hydrophilicity have biophysical properties
that are comparable to the wild-type sequence. This
approach may be universally applicable to a large set of
4E10-derived peptides to identify a hydrophilic sequence
that induces a broadly neutralizing antibody response.
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